Cineplex Price Target Increased to C$36.00 by Analysts at Canaccord Genuity (CGX)
Research analysts at Canaccord Genuity boosted their price target on shares of Cineplex (TSE:CGX) from C$35.00 to C$36.00 in a report released on Monday, AnalystRatingsNetwork reports. The firm currently has a “hold” rating on the stock. Canaccord Genuity’s price target would indicate a potential downside of 10.43% from the stock’s previous close.
Cineplex (TSE:CGX) traded up 0.15% on Monday, hitting $40.25. 58,414 shares of the company’s stock traded hands. Cineplex has a 1-year low of $29.62 and a 1-year high of $40.51. The stock’s 50-day moving average is $38.96 and its 200-day moving average is $36.66. The company has a P/E ratio of 20.30.
The company also recently announced a oct 13 dividend, which is scheduled for Friday, November 29th. Stockholders of record on Thursday, October 31st will be paid a dividend of $0.12 per share.
Other equities research analysts have also recently issued reports about the stock. Analysts at CIBC reiterated a “sector outperform” rating on shares of Cineplex in a research note to investors on Friday, October 11th. They now have a C$42.00 price target on the stock. Separately, analysts at Scotiabank initiated coverage on shares of Cineplex in a research note to investors on Friday, October 11th. They set an “outperform” rating and a C$41.00 price target on the stock. Finally, analysts at RBC Capital raised their price target on shares of Cineplex from C$39.00 to C$40.00 in a research note to investors on Monday, October 7th. They now have a “sector perform” rating on the stock. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Cineplex currently has a consensus rating of “Buy” and an average price target of C$38.65.
Cineplex Inc (TSE:CGX) directly and indirectly owns 100% of Cineplex Entertainment Limited Partnership (the Partnership).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.